What is it about?
Imipenem MIC >=2 mg/L, cefepime MIC >8 mg/L, and isolates cultured from the peritoneal space were the independent predictors as carbapenemase producers of ertapenem-non-susceptible isolates (NDM, and IMP producers predominantly) causing intra-abdominal infections
Featured Image
Why is it important?
These results might help us with judging the emergence of carbapenemase producers among ertapenem-non-susceptible intra-abdominal Enterobacteriaceae isolates, and further decide which antimicrobial agents should be chosen correctly
Perspectives
Read the Original
This page is a summary of: Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance ..., Infection and Drug Resistance, October 2018, Dove Medical Press,
DOI: 10.2147/idr.s181085.
You can read the full text:
Contributors
The following have contributed to this page